EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieVergleichsstudie

Ten-year outcomes of valve-replacing versus valve-sparing aortic root replacement in patients with Marfan syndrome: An observational multicenter study

Joseph S Coselli, D Craig Miller, Irina Volguina, Iván Murrieta-Álvarez, Susan Y Green, Thoralf M Sundt, Leonard N Girardi, Nimesh D Desai, Heidi M Connolly, Michael A Borger, Marc R Moon, Scott A LeMaire und 1 weitere

The Journal of Thoracic and Cardiovascular Surgery · 2026

DOI: 10.1016/j.jtcvs.2026.04.044 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2026. Verfasst von Joseph S Coselli und 12 weiteren Autor:innen. Beteiligte Einrichtung: Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex; The Texas Heart Institute at Baylor College of Medicine, Houston,…. Hauptthemen laut MEDLINE: Marfan Syndrome, Aortic Valve, Blood Vessel Prosthesis Implantation, Aortic Valve Insufficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Baylor College of Medicine, Marfan Foundation, Stanford University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: We compared 10-year outcomes of aortic valve-replacing (AVR) and aortic valve-sparing (AVS) root replacement in patients with Marfan syndrome (MFS). METHODS: Patients who met strict Ghent diagnostic criteria for MFS and who underwent either AVR or AVS between March 1, 2005, and December 31, 2010, were enrolled in a 3-year prospective observational study. The follow-up, which was clinical and echocardiographic, was later extended to 20 years. Time-to-event analyses were performed with and without inverse probability weighting to adjust for baseline differences; comparison between groups assessed major adverse valve-related (MAVRE) and other events. RESULTS: Of 316 patients enrolled, 77 underwent AVR and 239 underwent AVS; 214 gave reconsent for 20-year follow-up. For survivors, median durations for clinical and echocardiographic follow-up were 12.1 years (interquartile range, 4.6-15.1 y) and 10.1 years (interquartile range, 3.0-14.1 y), respectively. Ten-year adjusted survival rates for the AVR and AVS groups were similar (77.9% ± 4.4% vs 88.4% ± 2.6%; P = .2), as were adjusted rates of MAVRE (36.1% ± 4.2% vs 35.0% ± 3.3%; P = .5). Inverse probability weighting-adjusted competing-risk modeling associated AVS with greater cumulative incidences of structural valve deterioration or nonstructural valve dysfunction (24.9% vs 4.4%; P = .01) and aortic regurgitation ≥2+ (26.5% vs none; P < .001); similar analysis associated AVR with a greater cumulative incidence of bleeding (23.2% vs 2.7%; P < .001). CONCLUSIONS: Ten years postoperatively, the accumulation of structural valve deterioration in patients who underwent AVS and bleeding events in patients who underwent AVR balance out in terms of MAVRE. We plan to follow this cohort for 20 years after aortic root replacement, which may reveal late differences in reintervention rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Marfan SyndromeAortic ValveBlood Vessel Prosthesis ImplantationAortic Valve InsufficiencyHumansFemaleTreatment OutcomeMaleProspective StudiesAdultTime FactorsAortic Root AneurysmRisk FactorsAdolescentYoung AdultPostoperative Complications

Stichwörter der Autor:innen

Marfan syndromeaortic regurgitationaortic valvebleedingroot replacement

Autor:innen und Institutionen

  • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex; The Texas Heart Institute at Baylor College of Medicine, Houston, Tex; Department of Cardiovascular Surgery, CHI St Luke's Health-Baylo…
  • Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif.
  • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex.
  • Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Mass.
  • Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY.
  • Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, Pa.

Förderung

  • Baylor College of Medicine
  • Marfan Foundation
  • Stanford University

Zitieren

APA

Coselli, J. S., Miller, D. C., Volguina, I., Murrieta-Álvarez, I., Green, S. Y., Sundt, T. M., Girardi, L. N., Desai, N. D., Connolly, H. M., Borger, M. A., Moon, M. R., LeMaire, S. A., & Aortic Valve Operative Outcomes in Marfan Patients Study Group (2026). Ten-year outcomes of valve-replacing versus valve-sparing aortic root replacement in patients with Marfan syndrome: An observational multicenter study. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2026.04.044

Vancouver

Coselli JS, Miller DC, Volguina I, Murrieta-Álvarez I, Green SY, Sundt TM, et al. Ten-year outcomes of valve-replacing versus valve-sparing aortic root replacement in patients with Marfan syndrome: An observational multicenter study. The Journal of Thoracic and Cardiovascular Surgery. 2026. doi:10.1016/j.jtcvs.2026.04.044

BibTeX
@article{Coselli2026,
  author = {Coselli, Joseph S and Miller, D Craig and Volguina, Irina and Murrieta-Álvarez, Iván and Green, Susan Y and Sundt, Thoralf M and Girardi, Leonard N and Desai, Nimesh D and Connolly, Heidi M and Borger, Michael A and Moon, Marc R and LeMaire, Scott A and Aortic Valve Operative Outcomes in Marfan Patients Study Group, Aortic Valve Operative Outcomes in Marfan Patients Study Group},
  title = {Ten-year outcomes of valve-replacing versus valve-sparing aortic root replacement in patients with Marfan syndrome: An observational multicenter study},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2026},
  doi = {10.1016/j.jtcvs.2026.04.044}
}
Kostenlos starten →